Navigation Links
Access Medical Laboratories, Inc. to Celebrate Grand Opening of New Laboratory Headquarters in Jupiter, Florida
Date:10/25/2011

JUPITER, Fla., Oct. 25, 2011 /PRNewswire/ -- Town officials, physicians from South Florida and around the country as well as people from the community will join Access Medical Laboratories, Inc. on November 8, 2011 to celebrate the completion of the new 25,000 square foot core laboratory and research facility located at 5151 Corporate Way in the Abacoa section of Jupiter. This event will be hosted by Access Medical Laboratories, Inc. President/CEO Mohamed El-Hosseiny, Senior Executive V.P./COO Susan El-Hosseiny and Vice Presidents Sharif, Ryan and Adam El-Hosseiny at 5:00 pm to 7:00 pm, with the ribbon cutting taking place at 5:15 pm. Among the featured guests at the ceremony will be Jupiter mayor Karen J. Golonka, Town Manager Andy Lucasik, Northern Palm Beach Chamber of Commerce staff, Medical Laboratory Director Dr. Alan Sara, MD, Dr. Mark L. Gordon, MD (Los Angeles, CA), who is also in charge of Access's traumatic brain injury research division, Dr. Mitchell Ghen, DO, PHD (Boca Raton, FL), Dr. Naina Sachdev, MD (Portland, OR) and Dr. Edwin Lee, MD, F.A.C.E. (Orlando, FL).

(Photo:  http://photos.prnewswire.com/prnh/20111025/FL92221 )

The state-of-the-art complex consolidates the majority of Access's operations into a single facility, which will foster the company's superior form of diagnostic laboratory services. Access broke ground on the new building in June 2010.

"Our new Headquarters will give us the ability to expand our menu of specialized testing domestically and internationally, bring in more researchers for our Anti-Aging & Esoteric divisions, take our world class customer service to a higher level and further our mission as a laboratory committed to excellence," said Ryan El-Hosseiny. The 3.5 acre site in Abacoa (Jupiter, FL) is where the 25,000 square foot state of the art diagnostic laboratory is located. This will create over 60 jobs in Jupiter's bio-tech community.  

About Access Medical Laboratories, Inc.

Since 2003, Access Medical Labs has been synonymous with innovation. The only one of its kind; Access has created a distinct, superior form of diagnostic laboratory service which has changed the outlook of the laboratory industry throughout the United States. Now in 2011, Access is well known around the world for its research in advanced cardiac, interventional endocrinology/anti-aging and microbiological testing. Access Medical Labs is also the only lab in the nation to develop a complete menu of saliva hormone testing on using the "Gold Standard" method, Liquid Chromatography/Mass Spectrometry (LC/MS/MS). Access Medical Labs will continue to introduce many new cutting edge technologies and a broader spectrum of clinical diagnostic testing.

Access Medical Laboratories™ is a registered trademark of Access Medical Laboratories, Inc.

For More information on Access Medical Laboratories:

www.accessmedlab.com


'/>"/>
SOURCE Access Medical Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
2. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
3. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
4. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
5. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
6. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
7. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
8. USDA Awards $1.5 Million to Expand Access to High-Quality Critical Care in Rural Communities
9. Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods
10. GeneNews provides Centocor access to its osteoarthritis program
11. Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and ... rebranding initiative announced today. The bold new look is part of a transformation ... moves into a significant growth period. , It will also expand its service offering ...
(Date:10/10/2017)... -- International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, Arizona ... market and how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase ... "The residential security market has experienced continued growth, ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):